Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 563 |
|---|
(No ratings)
Dr. Daniel R. Wynn, MD is a neurologist in Northbrook, IL specializing in neurology (brain & spinal cord disease) and neurophysiology. He graduated from Rosalind Franklin University of Medicine and Science, Chicago Medical School. Dr. Daniel R. Wynn, MD is affiliated with Endeavor Health and Advocate Health Care.
Advocate Health Care
Attention Deficit Disorder (ADD/ADHD)
Attention Deficit Hyperactivity Disorder, or ADHD, is one of the most common disorders diagnosed in children. Nine percent of children in the USA have been diagnosed with ADHD. Symptoms, which include hyperactivity and difficulty maintaining focus or paying attention, can last into adulthood for some patients. Boys are four times as likely to be diagnosed as girls, although experts don't know why this is.
There are three main types of ADHD:
When diagnosing ADHD, it is important to rule out other issues that may be causing the symptoms. Seizure disorders, hearing loss, anxiety, and domestic problems are some examples of problems that can cause behaviors similar to those seen with ADHD.
Treatment can include stimulant medications, behavioral therapy to teach patients ways to navigate their world and control symptoms better, and accommodations at school or work. A structured environment (with lots of organization and well-defined rules) seems to help most kids with ADHD function at their best.
ADHD is mainly thought of as a disorder that affects children, but symptoms can last into adulthood for a third to half of those diagnosed. In adults, ADHD has similar symptoms as when it is seen in children: impulsive behavior, difficulty maintaining focus, being easily distracted, or a tendency to fidget. These symptoms can cause problems in a patient's careers and relationships. Additionally, adults with ADHD are at increased risk for substance abuse. Medications can be an important part of treatment for adults, as well as stress reduction techniques and organization skills training. Specialized ADHD coaches can help adults with ADHD manage their symptoms and succeed in all areas of their life.
Sleep Study
A sleep study reveals important insights about a patient's sleep patterns by measuring brain activity, breathing, and movement. There are five types of sleep studies: a polysomnogram, titration sleep study, split night sleep study, multiple sleep latency test, and at-home sleep study. Sleep studies may help identify conditions such as:
The most widely performed sleep test is the traditional polysomnogram (PSG). This test is typically used to determine whether patients have sleep apnea (lapses in breathing while asleep). Polysomnograms are conducted overnight in a specialized sleep clinic or sleep center, where a patient enters the sleep center and is assigned to a room with a bed, medical equipment, and monitoring system. An overnight sleep technician attaches electrodes to the patient's head, chest, and legs. This application process lasts for around an hour. A sleep technician watches and evaluates the patient as they sleep. Objects such as a comfortable pillow from home, toiletries, and small personal items may be helpful in easing patients into sleep in unfamiliar surroundings.
Patients receive their physician-interpreted sleep study results within a few weeks of the test. If sleep apnea is detected, patients may be asked to return for a titration sleep study. A titration study involves the same procedures and electrode placement of a polysomnogram, but also includes a mask attached to a CPAP (continuous positive airway pressure) machine. The CPAP machine brings pressurized air to the patient. The technician may monitor and adjust the CPAP's air pressure throughout the night. The purpose of a titration study is to determine the appropriate air pressure for patients with obstructive sleep apnea (blocked upper airway).
A split night study combines the polysomnogram and titration sleep studies into two sessions on the same night. Split night studies enable patients to complete both studies quickly instead of waiting weeks in between tests and may expedite the interpretation of results and treatment.
Multiple sleep latency test (MSLT) measures how fast someone is able to fall asleep. Unlike other sleep tests, this test is performed during the day. It may take place after an overnight sleep study. The MSLT test monitors napping and potential for daytime sleepiness and exhaustion.
At-home sleep tests are fully conducted by patients in their own homes. Patients attach fewer electrodes, a breathing sensor, a microphone, and a data collection device to themselves and sleep in their own beds. The following morning, patients gather the data collection device and return it to their medical providers. While at-home sleep tests are convenient, they are not recommended for patients with severe sleep problems. At-home sleep tests are less precise than clinical tests and do not measure brain activity.
Sleep studies are essential to helping patients receive accurate sleep disorder diagnoses and proper treatment. A sleep study can be the first step towards higher quality sleep and physical health.
Stroke
A stroke is a medical emergency that occurs when a blood vessel supplying oxygen and nutrients to the brain is ruptured or blocked. The brain cannot function without a steady supply of oxygen and nutrients, so when the blood supply to the brain is interrupted, even for a brief moment, brain cells begin to die. When a sufficient number of brain cells die, the brain itself can no longer function, meaning that strokes are very dangerous. Strokes can result in impaired movement, speech, cognitive ability, the impairment of important physical functions, and even death.
Anyone can have a stroke, regardless of age and health. Strokes are known to happen at random. However, certain conditions and behaviors can increase one's risk of stroke over time.
Risk factors for stroke include:
There are two main types of stroke: ischemic stroke and hemorrhagic stroke. Ischemic stroke occurs more commonly and is when a blood vessel in the brain becomes blocked. Blockages are caused by blood clots and built-up plaque (deposits of fat and cholesterol), which leads to atherosclerosis, a condition where the blood vessels narrow and harden. The resultant restricted blood flow may lead to an ischemic stroke by blocking essential oxygen to the brain, causing the heart to exert more effort to pump blood.
Hemorrhagic stroke occurs when a blood vessel in or around the brain ruptures. The burst vessel leaks blood into surrounding brain tissue, causing irreparable brain damage.
Hemorrhagic strokes are less common and may occur from head injuries, brain aneurysms, brain tumors, and bleeding disorders, amongst other conditions.
Both ischemic and hemorrhagic strokes require immediate medical treatment. Medical intervention can prevent severe and life-threatening brain damage. Signs of stroke include:
-Disorientation or confusion
-Difficulty speaking
-Difficulty walking
-Impaired vision
-Weakness in the face, legs, or arms
-Severe headaches
When someone suspected of having a stroke reaches the hospital, the patient will usually receive a CT or other scan that provides an image of the brain. The scan results can reveal clotted or leaking blood in the brain. Physical exams, neurological exams, and blood tests may also be used to check for blood clotting and sugar. Treatment begins generally immediately if a stroke is detected.
Medical treatment for ischemic strokes includes a thrombolytic medicine which breaks up and disperses blood clots. This medicine can greatly improve stroke recovery and long-term health. However, the thrombolytic medicine must be administered as soon as possible to achieve these results. Other treatments for ischemic strokes are blood thinners and thrombectomy, a surgical procedure to remove a blood clot in the brain. Thrombectomy is performed by inserting a catheter (thin needle) into the artery to reach the blood clot and mechanically remove it. With the clot removed, normal blood flow to the brain resumes. Thrombectomy is typically performed at most six hours after a patient shows signs of a stroke.
Hemorrhagic strokes are treated with blood-saving medication and surgery. For a hemorrhagic stroke caused by the rupture of an aneurysm (blood vessel bulges), surgery to stem the bleeding aneurysm and vessel may be used. One surgical technique is stent-assisted coiling, which adds a stent (small wire-meshed tube) into the blood vessel to block the leaking opening of the aneurysm. A non-surgical procedure is endovascular coiling, where a catheter (thin, hollow needle) places a platinum wire coil at the spot of the aneurysm. The coil blocks bleeding and prevents the aneurysm from continuing to leak blood. These procedures are usually combined with blood-thickening medications. Blood transfusions may be administered if substantial blood loss has occurred.
Since stroke patients may have lost some essential functions while the blood flow to their brains was obstructed, both ischemic stroke and hemorrhage stroke patients may receive post-stroke rehabilitation to rebuild their physical and mental abilities. Some restorative treatments include occupational, physical, and speech therapy. Patients may also receive care from neurologists, who can assist patients in recovering certain brain functions and cognitive abilities, and rehabilitation psychologists, who may help patients with their emotional, behavioral, and cognitive recovery. Some stroke patients require lengthy rehabilitation and may never fully regain function, while others may recover more quickly. While the fastest recovery improvements are usually seen in the first three or four months, stroke rehabilitation can last for years.
If someone begins to show signs of stroke, contact emergency services and call 9-1-1 immediately since blood flow must be restored as soon as possible to help avoid significant brain damage. If an ambulance takes the person to the hospital, paramedics can initiate stroke treatment as soon as the patient enters the ambulance, allowing for more prompt medical intervention and care.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 563 |
|---|
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 538 |
|---|
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 67 |
|---|---|
| Female | 214 |
| Non-Hispanic White | 255 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 92 |
|---|---|
| From 75 to 84 | 49 |
| 85 and over | 15 |
| Less than 65 | 125 |
| Hypertension | 43 |
|---|---|
| High Cholesterol | 35 |
| Stroke | 0 |
| Ischemic Heart Disease | 16 |
| Depression | 24 |
| Chronic Kidney Disease | 10 |
| Asthma | 0 |
| Osteoperosis | 8 |
| Atrial Fibrilation | 5 |
| Heart Failure | 6 |
| Chronic Obstructive Pulmonary Disease | 6 |
| Diabetes | 15 |
| Dementia | 11 |
| Cancer | 5 |
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 558 |
|---|
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 68 |
|---|---|
| Female | 194 |
| Non-Hispanic White | 235 |
|---|---|
| Black | 0 |
| Hispanic | 11 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 99 |
|---|---|
| From 75 to 84 | 39 |
| 85 and over | 13 |
| Less than 65 | 111 |
| Hypertension | 40 |
|---|---|
| High Cholesterol | 35 |
| Stroke | 0 |
| Ischemic Heart Disease | 14 |
| Depression | 27 |
| Chronic Kidney Disease | 8 |
| Asthma | 0 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 4 |
| Heart Failure | 8 |
| Chronic Obstructive Pulmonary Disease | 6 |
| Diabetes | 13 |
| Dementia | 10 |
| Cancer | 5 |
The top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL during 2015 were sleep study.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 525 |
|---|---|
| sleep study | 37 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 150 |
|---|---|
| Female | 374 |
| Non-Hispanic White | 460 |
|---|---|
| Black | 0 |
| Hispanic | 24 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 210 |
|---|---|
| From 75 to 84 | 72 |
| 85 and over | 22 |
| Less than 65 | 220 |
| Hypertension | 44 |
|---|---|
| High Cholesterol | 37 |
| Stroke | 0 |
| Ischemic Heart Disease | 15 |
| Depression | 32 |
| Chronic Kidney Disease | 10 |
| Asthma | 5 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 6 |
| Heart Failure | 9 |
| Chronic Obstructive Pulmonary Disease | 6 |
| Diabetes | 15 |
| Dementia | 8 |
| Cancer | 8 |
The top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL during 2016 were sleep study.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 563 |
|---|---|
| sleep study | 42 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 73 |
|---|---|
| Female | 197 |
| Non-Hispanic White | 239 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 119 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 109 |
| Hypertension | 44 |
|---|---|
| High Cholesterol | 37 |
| Stroke | 0 |
| Ischemic Heart Disease | 15 |
| Depression | 29 |
| Chronic Kidney Disease | 15 |
| Asthma | 10 |
| Osteoperosis | 10 |
| Atrial Fibrilation | 6 |
| Heart Failure | 8 |
| Chronic Obstructive Pulmonary Disease | 7 |
| Diabetes | 18 |
| Dementia | 10 |
| Cancer | 6 |
The top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL during 2017 were sleep study.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 655 |
|---|---|
| sleep study | 30 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 102 |
|---|---|
| Female | 209 |
| Non-Hispanic White | 268 |
|---|---|
| Black | 12 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 16 |
| Native American | 0 |
| From 65 to 74 | 141 |
|---|---|
| From 75 to 84 | 49 |
| 85 and over | 11 |
| Less than 65 | 110 |
| Hypertension | 42 |
|---|---|
| High Cholesterol | 32 |
| Stroke | 0 |
| Ischemic Heart Disease | 16 |
| Depression | 26 |
| Chronic Kidney Disease | 16 |
| Asthma | 5 |
| Osteoperosis | 10 |
| Atrial Fibrilation | 4 |
| Heart Failure | 6 |
| Chronic Obstructive Pulmonary Disease | 4 |
| Diabetes | 18 |
| Dementia | 10 |
| Cancer | 10 |
The top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL during 2018 were sleep study.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 672 |
|---|---|
| sleep study | 13 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 92 |
|---|---|
| Female | 207 |
| Non-Hispanic White | 265 |
|---|---|
| Black | 11 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 12 |
| Native American | 0 |
| From 65 to 74 | 143 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 102 |
| Hypertension | 46 |
|---|---|
| High Cholesterol | 43 |
| Stroke | 4 |
| Ischemic Heart Disease | 20 |
| Depression | 29 |
| Chronic Kidney Disease | 16 |
| Asthma | 5 |
| Osteoperosis | 10 |
| Atrial Fibrilation | 5 |
| Heart Failure | 6 |
| Chronic Obstructive Pulmonary Disease | 6 |
| Diabetes | 18 |
| Dementia | 7 |
| Cancer | 7 |
The top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL during 2019 were sleep study.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 646 |
|---|---|
| sleep study | 13 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 101 |
|---|---|
| Female | 193 |
| Non-Hispanic White | 260 |
|---|---|
| Black | 11 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 12 |
| Native American | 0 |
| From 65 to 74 | 154 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 100 |
| Hypertension | 42 |
|---|---|
| High Cholesterol | 42 |
| Stroke | 0 |
| Ischemic Heart Disease | 18 |
| Depression | 31 |
| Chronic Kidney Disease | 16 |
| Asthma | 5 |
| Osteoperosis | 13 |
| Atrial Fibrilation | 6 |
| Heart Failure | 7 |
| Chronic Obstructive Pulmonary Disease | 5 |
| Diabetes | 18 |
| Dementia | 7 |
| Cancer | 7 |
The top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL during 2020 were sleep study.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 767 |
|---|---|
| sleep study | 24 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 102 |
|---|---|
| Female | 201 |
| Non-Hispanic White | 270 |
|---|---|
| Black | 12 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 167 |
|---|---|
| From 75 to 84 | 42 |
| 85 and over | 13 |
| Less than 65 | 81 |
| Hypertension | 41 |
|---|---|
| High Cholesterol | 46 |
| Stroke | 4 |
| Ischemic Heart Disease | 17 |
| Depression | 33 |
| Chronic Kidney Disease | 18 |
| Asthma | 6 |
| Osteoperosis | 13 |
| Atrial Fibrilation | 5 |
| Heart Failure | 9 |
| Chronic Obstructive Pulmonary Disease | 5 |
| Diabetes | 18 |
| Dementia | 11 |
| Cancer | 8 |
The top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL during 2021 were sleep study.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 736 |
|---|---|
| sleep study | 22 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 106 |
|---|---|
| Female | 211 |
| Non-Hispanic White | 287 |
|---|---|
| Black | 12 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 160 |
|---|---|
| From 75 to 84 | 61 |
| 85 and over | 15 |
| Less than 65 | 81 |
| Hypertension | 48 |
|---|---|
| High Cholesterol | 47 |
| Stroke | 4 |
| Ischemic Heart Disease | 22 |
| Depression | 35 |
| Chronic Kidney Disease | 23 |
| Asthma | 7 |
| Osteoperosis | 15 |
| Atrial Fibrilation | 7 |
| Heart Failure | 10 |
| Chronic Obstructive Pulmonary Disease | 6 |
| Diabetes | 19 |
| Dementia | 11 |
| Cancer | 7 |
The top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL during 2022 were sleep study.
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
| doctor visit | 661 |
|---|---|
| sleep study | 15 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 101 |
|---|---|
| Female | 212 |
| Non-Hispanic White | 288 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 156 |
|---|---|
| From 75 to 84 | 67 |
| 85 and over | 13 |
| Less than 65 | 77 |
| Hypertension | 57 |
|---|---|
| High Cholesterol | 66 |
| Stroke | 13 |
| Ischemic Heart Disease | 21 |
| Depression | 31 |
| Chronic Kidney Disease | 13 |
| Asthma | 8 |
| Osteoperosis | 21 |
| Atrial Fibrilation | 12 |
| Heart Failure | 12 |
| Chronic Obstructive Pulmonary Disease | 10 |
| Diabetes | 19 |
| Dementia | 4 |
| Cancer | 12 |
Volume of procedures performed by Dr. Daniel R. Wynn, MD for Medicare patients.
The highest averages for the top procedures that Dr. Daniel R. Wynn, MD treated as a neurologist in Northbrook, IL were sleep study.
| doctor visit | 625 |
|---|---|
| sleep study | 24 |
Information about Medicare patients treated by Dr. Daniel R. Wynn, MD.
| Male | 87 |
|---|---|
| Female | 201 |
| Black / African American | 5 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 257 |
| Native American / Alaskan Native | 0 |
| Hispanic | 3 |
| Other | 3 |
| 75 to 84 | 34 |
|---|---|
| 85 and over | 9 |
| Less than 65 | 101 |
| 65 to 74 | 131 |
The highest averages of the most common conditions of Medicare patients that Dr. Daniel R. Wynn, MD treated were hypertension, high cholesterol, depression and diabetes.
| Hypertension | 40 |
|---|---|
| High Cholesterol | 38 |
| Stroke | 2 |
| Ischemic Heart Disease | 15 |
| Depression | 27 |
| Chronic Kidney Disease | 13 |
| Asthma | 4 |
| Osteoporosis | 10 |
| Heart Failure | 7 |
| Chronic Obstructive Pulmonary Disease | 5 |
| Diabetes | 15 |
| Atrial Fibrillation | 5 |
| Dementia | 8 |
| Cancer | 6 |
Dr. Daniel R. Wynn, MD graduated from Rosalind Franklin University of Medicine and Science, Chicago Medical School. He completed residency at Mayo Clinic. He is certified by the American Board of Psychiatry and Neurology and has a state license in Illinois.
Medical School: Rosalind Franklin University of Medicine and Science, Chicago Medical School
Residency: Mayo Clinic (1988)
Board Certification: American Board of Psychiatry and Neurology (1988)
Licensed In: Illinois
Dr. Daniel R. Wynn, MD is associated with these hospitals and organizations:
Dr. Daniel R. Wynn, MD appears to accept the following insurance providers: CIGNA Choice Fund PPO, United Healthcare Select Plus POS, United Healthcare Select HMO, United Healthcare Select EPO, United Healthcare Options PPO, United Healthcare Indemnity, Aetna POS, Aetna QPOS, TRICARE Prime, Aetna Open Choice PPO, Aetna Open Access HMO, Aetna Medicare HMO, Golden Rule, TRICARE, Coventry, Aetna Open Access Aetna Select, Aetna Select, Aetna EPO, Aetna HMO, Blue Advantage PPO, Aetna Medicare PPO, United Healthcare Select Plus HMO, United Healthcare Choice Plus PPO, AARP, Medicare Advantage, Humana Medicare Choice PPO, United Healthcare Choice Plus HMO, Blue Cross PPO, Blue Advantage HMO, Blue Cross Medicare Advantage PPO, Coventry PPO, United Healthcare, Medicaid, Humana, Cigna, United Healthcare Navigate HMO, First Health, HealthLink PPO, HFN EPO, HFN PPO, HFN Platinum EPO, HFN, PHCS PPO, MultiPlan PPO, SEIU - Local 4 PPO, Union Medical (Local 1546) HMO, Aetna Medicare Prime HMO-POS, Union Medical Care PPO, Aetna Elect Choice HMO (includes Aetna Health Funds), AAH UMR Select - Team Member Plan, Aetna Medicare POS, Aetna State of Illinois Open Access Plus, Aetna Open Choice POS, Health Services and Technology, HST Care Connect PPO, Aetna Open Choice PPO - State of Illinois - SOI, United Surest (previously Bind), Aetna Managed Choice (MC) POS, Union Health Services, Inc., Aetna Open Choice POS II, Aetna State of Illinois PPO, Aetna Health Network Option, Health Services and Technology, HST Care Connect EPO, AAH UMR Preferred - Team Member Plan, Aetna Signature Administrators PPO (ASA or SRC) PPO, Aetna Upfront Advantage, Aetna Signature Administrators PPO, SEIU - Local 4 HMO, Aetna Open Access Elect Choice (includes Aetna Health Funds), Aetna NAP - PPO, Aetna Value Performance Network, Aetna Premier Care Plus Network, Blue Cross Community MMAI, BlueCare Direct HMO, Aetna Health Network Only, Aetna Premier Care Network, Blue Cross Medicare Supplement PPO and SIHO PPO.
According to our sources, Dr. Daniel R. Wynn, MD accepts the following insurance providers:
Dr. Daniel R. Wynn, MD does not have any reviews yet, be the first to leave a review of Dr. Daniel R. Wynn, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Daniel R. Wynn, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| GENZYME CORPORATION |
$1,023,398
AUBAGIO $588,117 |
LEMTRADA $371,941 |
ALEMTUZUMAB $18,947 |
MS DISEASE STATE $270 |
LUMIZYME $142 |
Other $43,981 |
|---|---|---|---|---|---|---|
| EMD Serono, Inc. |
$307,145
Rebif $151,999 |
Mavenclad $144,377 |
MSC2364447C $9 |
$10,760 |
||
| Teva Pharmaceuticals USA, Inc. |
$306,720
COPAXONE $246,906 |
AJOVY $18,108 |
NUVIGIL $16,809 |
No Product Specified $7,443 |
68546-0317-3 $6,000 |
Other $11,454 |
| Acorda Therapeutics, Inc |
$111,224
AMPYRA $111,028 |
INBRIJA $196 |
||||
| Mallinckrodt LLC |
$100,518
ACTHAR $100,493 |
GABLOFEN $25 |
||||
| Other |
$682,678
ZEPOSIA $90,238 |
Nuedexta $85,392 |
ACTHAR $77,657 |
Rebif $52,110 |
Gilenya $50,767 |
Other $326,515 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,709,158 |
|---|---|
| Consulting Fee | $235,198 |
| Honoraria | $229,024 |
| Travel and Lodging | $211,533 |
| Food and Beverage | $91,952 |
| Other | $54,817 |
Dr. Daniel R. Wynn, MD has received 960 research payments totaling $12,779,360.
Dr. Daniel Wynn practices neurophysiology and neurology (brain & spinal cord disease). Dr. Wynn's areas of expertise include concussion, migraine, and nerve block. He accepts Aetna EPO, Blue California, Coventry, and more. He obtained his medical school training at Rosalind Franklin University of Medicine and Science, Chicago Medical School and performed his residency at Mayo Clinic. He speaks Spanish. Dr. Wynn is professionally affiliated with Endeavor Health and Advocate Illinois Masonic Medical Center.